Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01084174 · ClinicalTrials.gov registry record · Phase 1
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
A Phase 1 study of Food Hypersensitivity and Peanut Hypersensitivity, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01084174 is a Phase 1 study of Food Hypersensitivity and Peanut Hypersensitivity that has completed, run by Johns Hopkins University. The registered enrollment target is 21 participants, below the 4,658-participant average among 5 other Food Hypersensitivity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01084174, a Phase 1 study of Food Hypersensitivity and Peanut Hypersensitivity, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore the safety and efficacy of a sublingual (under the tongue) immunotherapy (SLIT) dosing regimen and an oral immunotherapy (OIT) regimen in inducing desensitization and long term tolerance in children with persistent peanut allergy.
Conditions Studied
Interventions
- DRUG Peanut powder
- DRUG Peanut extract
- DRUG Placebo extract
- DRUG Placebo powder
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01084174
The ClinicalTrials.gov registry entry for NCT01084174 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,658-participant average among 5 other Food Hypersensitivity trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Food Hypersensitivity appearing as the primary indexed condition, and to 4 interventions - of which Peanut powder is the first listed.
NCT01084174 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01084174 about?
NCT01084174 is a clinical study titled "A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy". The purpose of this study is to explore the safety and efficacy of a sublingual (under the tongue) immunotherapy (SLIT) dosing regimen and an oral immunotherapy (OIT) regimen in inducing desensitization and long term tolerance in children with persistent peanut allergy.
What is the current status of trial NCT01084174?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2010-03. Estimated completion is 2013-01.
What conditions does trial NCT01084174 study?
This clinical trial studies the following conditions: Food Hypersensitivity, Peanut Hypersensitivity, Immediate Hypersensitivity.
What interventions are being tested in trial NCT01084174?
The interventions under investigation include: Peanut powder (DRUG), Peanut extract (DRUG), Placebo extract (DRUG), Placebo powder (DRUG).
Who is sponsoring clinical trial NCT01084174?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01084174 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
RECRUITING · Phase 1
-
A Registry for the Food Allergy Community
RECRUITING
-
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
RECRUITING · Phase 2
-
Study of Milk Allergy and Tolerance in Children
COMPLETED · Phase 2
-
A Study of Sublingual Immunotherapy in Peanut-allergic Children
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.